The Practical Approach in the Clinic AOMs are incredibly effective tools for treating the chronic disease of obesity, but they are not standalone cures
Appetite shifts feel more organic and less forced
PCOS Sisters focuses on long-term strategies that may include: metabolic support medications, insulin-targeted therapies, & hormone-informed maintenance plans GLP-1 treatment at PCOS Sisters is often incorporated into our broader evidence backed metabolic program
Novo Nordisk published a cross-trial comparison claiming its Wegovy pill produced greater weight loss than Eli Lilly $LLY's newly approved obesity tablet Foundayo, raising the stakes as the two companies compete to shape prescribing trends in the oral GLP-1 market.
The response rate proved equally impressive: 91.7% of participants at the 12mg dose achieved at least 10% weight loss, and the majority achieved 15% or greater
Starting at a microdose lets the body gently adjust to the medication, often eliminating the need for aggressive symptom management
